(Q35553351)

8 August 2017

1 reference

title

The role of haploidentical stem cell transplantation in the management of children with haematological disorders (English)

1 reference

8 August 2017

Paul Veys

1

1 reference

8 August 2017

Persis Amrolia

2

1 reference

8 August 2017

Kanchana Rao

3

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.2003.04655.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.2003.04655.x

19 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

British Journal of Haematology

19 March 2024

published in

1 reference

8 August 2017

123

1 reference

8 August 2017

2

1 reference

8 August 2017

193-206

1 reference

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

8 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04655.X

Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04655.X

Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

19 March 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study

19 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

19 March 2024

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

19 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Haploidentical stem cell transplantation in leukemia.

19 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

19 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis

19 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow

19 March 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Marrow transplantation from related donors other than HLA-identical siblings

19 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

19 March 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts

19 March 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance

19 March 2024

17

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

19 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

CD34+ selected cells in mismatched stem cell transplantation: a single centre experience of haploidentical peripheral blood stem cell transplantation

19 March 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process

19 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Successful engraftment of haploidentical stem cell transplant for familial haemophagocytic lymphohistiocytosis using both bone marrow and peripheral blood stem cells

19 March 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: estab

19 March 2024

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Successful haploidentical bone marrow transplantation in Fanconi anemia

19 March 2024

28

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors

19 March 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

19 March 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation

19 March 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

European experience of bone-marrow transplantation for severe combined immunodeficiency

19 March 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Molecular mechanism for ganciclovir resistance in human T lymphocytes transduced with retroviral vectors carrying the herpes simplex virus thymidine kinase gene.

19 March 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants

19 March 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group

19 March 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells

19 March 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Transplantation of anergic histoincompatible bone marrow allografts

19 March 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Transplantation of megadoses of purified haploidentical stem cells

19 March 2024

40

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

19 March 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Hematopoietic stem cell transplants from unrelated donors

19 March 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant

19 March 2024

44

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

19 March 2024

46

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment

19 March 2024

53

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Transplantation of CD34-enriched peripheral stem cells from an HLA-haplotype mismatched donor to a patient with severe aplastic anemia

19 March 2024

56

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients

19 March 2024

57

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

19 March 2024

58

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.

19 March 2024

60

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Non-endocrine late complications of bone marrow transplantation in childhood: part II.

19 March 2024

61

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Successful therapy of metastatic cancer using tumor vaccines in mixed allogeneic bone marrow chimeras

19 March 2024

62

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Prevention of graft rejection in allogeneic bone marrow transplantation: I. Preclinical studies with antithymocyte globulins

19 March 2024

63

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

HLA class I specific inhibitory receptors

19 March 2024

67

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation

19 March 2024

68

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

19 March 2024

70

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulin

19 March 2024

72

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

The use of radioimmunoconjugates in stem cell transplantation.

19 March 2024

73

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants

19 March 2024

74

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice

19 March 2024

77

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Anti-Third Party CD8+ CTLs as Potent Veto Cells

19 March 2024

78

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells.

19 March 2024

79

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor.

19 March 2024

80

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation

19 March 2024

82

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia

19 March 2024

83

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Genetically haploidentical stem cell transplantation for acute leukemia

19 March 2024

86

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

19 March 2024

87

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

19 March 2024

89

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Programmed Cell Death of T Cells Signaled by the T Cell Receptor and the α 3 Domain of Class I MH

19 March 2024

90

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms.

19 March 2024

91

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device

19 March 2024

92

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

19 March 2024

94

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT)

19 March 2024

97

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell

19 March 2024

98

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft

19 March 2024

100

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling

19 March 2024

103

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath

19 March 2024

104

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.

19 March 2024

106

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

19 March 2024

108

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation

19 March 2024

109

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation

19 March 2024

110

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04655.X

19 March 2024

Identifiers

1 reference

8 August 2017

1 reference